NSE:IPCALAB

Ipca Laboratories Limited · NSE · Healthcare · INR · FY for 2026

Figures on this page computed 2026-11-08 12:26 UTC

Last close

n/aINR

Market data

  • 43.2xP/E

    Price / Earnings per Share (diluted)

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    INR
    • computed
    • Computed from the filing for 2026
  • 21.2%ROIC

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    INR
    • Computed from the filing for 2026
    • Computed from the filing for 2026
    • Computed from the filing for 2026
    • Computed from the filing for 2026
    • Computed from the filing for 2026
    • Computed from the filing for 2026
  • 11.8%Net margin

    Net Income / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    INR
    • Computed from the filing for 2026
    • Computed from the filing for 2026
  • 5.0%FCF margin

    Free Cash Flow / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    INR
    • Computed from the filing for 2026
    • Computed from the filing for 2026
  • 0.10Debt/equity

    Total Debt / Shareholders' Equity

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    INR
    • Computed from the filing for 2026
    • Computed from the filing for 2026
  • 0.1%Dividend yield
    Source
    computed
    Taken on
    2026-11-08
    Reported in
    INR
    • computed

Five bars, one line

lens 7 of 9
1.64x
1.78x
1.26x
0.95x
n/a
SalesProfitFree cash flowDebtPrice
Each bar against this company's own average; the line is that average.
Computed2026
Computed2026
Computed2026
Computed2026
Market datan/a

Each against its own average

4 of 5 read

Except where said otherwise: Computed from the filing for 2026

  • Sales1.64x

    Its own average over 10 years, 58.66B.

  • Profit1.78x

    Its own average over 10 years, 6.41B.

  • Free cash flow1.26x

    Its own average over 10 years, 3.87B.

  • Debt0.95x

    Its own average over 10 years, 8.47B.

  • Pricen/a

    Its own average over 0 years. Market data

Profit is furthest from its own average, at 1.78 times.

Sales is 1.64 times its own 10-year average; Profit is 1.78 times its own 10-year average; Free cash flow is 1.26 times its own 10-year average; Debt is 0.95 times its own 10-year average.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2026

  • Sales against its own 10-year average1.64
    Source
    computed
    Statement
    income
    Fiscal year
    2026
    Reported in
    INR
  • Profit against its own 10-year average1.78
    Source
    computed
    Statement
    income
    Fiscal year
    2026
    Reported in
    INR
  • Free cash flow against its own 10-year average1.26
    Source
    computed
    Statement
    income
    Fiscal year
    2026
    Reported in
    INR
  • Debt against its own 10-year average0.95
    Source
    computed
    Statement
    income
    Fiscal year
    2026
    Reported in
    INR
  • Price against its own 0-year averagen/aMarket data

    Not held.

    Source
    market
    Reported in
    INR

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.